Navigation Links
seca Supports Obesity Therapy with the New medical Body Composition Analyzer

HAMBURG, Germany, Sept. 4, 2013 /PRNewswire/ -- Earlier this Summer, the American Medical Association officially classified obesity as a disease that requires a range of medical interventions for treatment and prevention. The cornerstone of a scientific approach to physician assisted weight loss is an accurate assessment and precise monitoring of body composition. seca, the global leader in medical measuring and weighing, has long recognized the importance and scope of the nation's obesity epidemic. In response to the need for a research grade accuracy in a medical body composition analyzer, seca introduces its medical Body Composition Analyzer 514 (seca mBCA 514).

The seca mBCA 514 measures: fat mass, fat free mass, total body water, intracellular water, extracellular water with reference method accuracy – in less than 20 seconds. These direct measurements, extensive race specific reference values and open fields for other lab indices give the seca mBCA the reliable diagnostic power that physicians need to evaluate a patient's fat distribution and total cardiovascular risk factors.

Equipped with an 8-point electrode Bioelectrical Impedance Analysis measurement method, the seca mBCA's unique standing-aid guarantees that the patient is always in the same measurement position. The seca mBCA offers decisive advantages for obesity interventions, including comprehensive assessment of a patient's general health and nutritional status, disease risk stratifications, precise monitoring of physiologic responses and compliance to therapy, and several other features. Caloric requirements, stored calories, energy output and resting energy expenditure are all reportable and uniquely graphed with optional patient-friendly versions that include explanations. The seca mBCA is EMR compatible and includes a stand-alone Body Composition EMR system.

For more information or to request a free product demonstration of the seca mBCA 514, call 1-800-542-7322 or visit

About seca Corporation

seca, the global leader in medical measuring and weighing, offers healthcare providers advanced wireless technology and system solutions that go beyond height and weight. Based on 170 years of quality German engineering, seca medical devices set the standard for innovation, design and reliability. On every continent, doctors and nurses in medical practices, hospitals and nursing homes rely on the high quality of seca's medical scales and measuring systems.  seca products range from pediatric scales and measuring systems, measuring stations and column scales, flat scales, height measuring systems, multifunctional and wheelchair scales, chair scales and specialized scales. To learn more about seca products visit

Press Contact:
seca North America
Lyndsey Nunez, Marketing Manager

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
2. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
3. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
4. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
5. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
6. Ventana Supports World Patient Safety Day, July 25
7. eCardio Supports the Carolinas HealthCare Foundation Through Grant for Heart Of A Champion Day
8. Verify Brand Supports the Proposed FDA Unique Device Identification (UDI) System for Medical Devices
9. Lilly Supports Research to Determine What a Dogs Nose Knows About People with Diabetes and Severe Hypoglycemia
10. Henry Schein Cares Supports Alliance for Oral Health Across Borders Leadership Event
11. Cardinal Health Supports Future Pharmacists With Nearly $1 Million In Scholarships
Post Your Comments:
(Date:11/27/2015)... 2015 --> ... online. The potential to save costs, improve treatment quality ... from fully exploited as yet. Here, particular emphasis is ... via mobile tablet or directly at the patients, bedside. ... ) -->      (Photo: ...
(Date:11/27/2015)... DUBLIN , Nov. 27, 2015 Research ... of the "Global Intrauterine Devices Market 2015-2019" ... --> In this report, the author ... intrauterine devices market for 2015-2019. To calculate the market ... of following type of products: Hormonal IUDs and copper ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... , ... ProSidebar: Fashion is a set of 30 kinetic edge ... video editors can easily add an informative sidebar to any FCPX production. Create ... featuring self-animating drop zones, lines, bars, and text with the ease of FCPX's drag ...
(Date:11/27/2015)... ... ... A simply groundbreaking television series, "Voices in America", which is hosted by Hollywood ... issues that are presently affecting Americans. Dedicated to providing the world with a wide ... subjects consumers focus on, one episode at a time. , In the latest ...
(Date:11/27/2015)... IL (PRWEB) , ... November 27, 2015 , ... ... of the largest, most successful and prominent nonprofit healthcare organizations in the country. ... governance involvement with various organizations, and helped advance the healthcare industry as a ...
(Date:11/26/2015)... ... 26, 2015 , ... Patients at Serenity Point Recovery, a ... on Thanksgiving Day to share the things that they are most grateful for ... YouTube channel, patients displayed what they wrote on index cards, describing the things ...
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
Breaking Medicine News(10 mins):